Sponsor Pipeline

Hemanext Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
2
Disease Areas
5
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-15 NCT06685848
Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion		 Enrollment closed, study ongoing
2026-08-15 NCT06685848
Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion		 date change Primary completion pushed: 2026-12-15 -> 2028-05
2026-08-15 NCT06685848
Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion		 date change Completion pushed: 2026-12-15 -> 2028-08
2026-08-12 NCT06743113
Hypoxic Red Blood Cells in Sickle Cell Anemia		 date change Primary completion pushed: 2028-04 -> 2029-04
2026-08-12 NCT06743113
Hypoxic Red Blood Cells in Sickle Cell Anemia		 date change Completion pushed: 2028-09 -> 2029-10
Active Trials by Phase
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Not specified
NCT06743113 Hypoxic Red Blood Cells in Sickle Cell Anemia Sickle Cell Anaemia Not Yet Recruiting
NCT06685848 Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion Hematologic Neoplasms Active, Not Recruiting
Disease Areas
Sickle Cell Disease (1) Thalassemia (1)
Get alerts when Hemanext's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free